Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics-Reference-Cited by-同舟云学术

Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics

Published:2014-12-01 Issue:1 Volume:30 Page:64-72
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

LeWitt Peter A.¹

Affiliation:

1. Parkinson's Disease and Movement Disorders Center; Henry Ford Hospital; West Bloomfield; Michigan; and the Department of Neurology; Wayne State University School of Medicine; Detroit Michigan USA

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference78 articles.

1. Aromatic amino acids and modification of parkinsonism;Cotzias;N Engl J Med,1967

2. Modification of Parkinsonism: chronic treatment with l-dopa;Cotzias;N Engl J Med,1969

3. Levodopa in the treatment of Parkinson's disease: the second consensus meeting;Olanow;Mov Disord,2004

4. 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists;Carlsson;Nature,1957

5. A brief history of levodopa;Hornykiewicz;J Neurol,2010

Cited by 264 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retinoic acid in Parkinson's disease: Molecular insights, therapeutic advances, and future prospects;Life Sciences;2024-10

2. Inhibition of NLRP3 inflammasome ameliorates LPS-induced neuroinflammatory injury in mice via PINK1/Parkin pathway;Neuropharmacology;2024-10

3. Biosensors for Parkinson’s Disease: Where Are We Now, and Where Do We Need to Go?;ACS Sensors;2024-08-27

4. Brain and muscles magnetic stimulation in a drug-free case of Parkinson’s disease: Motor improvements concomitant to neuroplasticty;Heliyon;2024-08

5. Human amniotic epithelial stem cell-derived dopaminergic neuron-like cells ameliorate motor dysfunction in a rat model of Parkinson's disease;Life Sciences;2024-08